| Session 1: EQA for rare diseases | ||
| Overview of EQAS for rare diseases in haematology | Barbara de la Salle | |
| Experience with an international EQAS for a rare disease : a clinical and analytical scheme for porphyrias | Sverre Sandberg | |
| General Discussion | ||
| Session 2: The educational role of EQA | ||
| The educational role of EQA: the organizer and laboratories perspectives | Jonna Pelanti | |
|
A digital morphology educational EQA scheme |
Michelle Brereton | |
| General Discussion | ||
| Session 3: Pre-analytical EQA | ||
| EQA schemes in the pre-analytical phase: how they contribute to reduce laboratory errors? | Mario Plebani | |
| SEQC: Preanalitycal Quality Control Program. Ten years experience | Nuria Barba | |
| Portuguese EQAS vision versus experience on pre-analytical phase (2007-2011) | Ana Paula Faria | |
| Session 4: Accreditation | ||
| Results of a questionnaire | Annette Thomas | |
| Adam Uldall Lecture | ||
| EQA in developing countries | André Deom | |
| Session 5: The role of EQA in method harmonisation | ||
| The AACC concept of method harmonisation | Gary Myers | |
| General Discussion on the role of EQA in method harmonisation | Piet Meijer | |
| Contributions from Working Group projects | ||
| Post-analytical external quality assessment of INR in primary and secondary care: an international survey. | Ann-Helen Kristoffersen | |
| Contribution of telemedecine to External Quality Assessment Scheme for blood smear and bone marrow interpretation: the Belgian experience | Bernard Chatelain | |
| Abstracts | ||
| Pre- and postanalytical surveys: a complementary service of EQA centers and valuable continuing education tool. | Xavier Albe | |
| Pre-analytical EQA scheme - a pilot study. | Gunn BB Kristensen | |
| The Key Incident Monitoring & Management Systems (KIMMS) project. | Alan Bateman | |
| Role of external quality assessment schemes in the standardization and postmarket vigilance | Janos Marki-Zay |
